N. Montes

发表

Theophylline and fibrocystic breast disease.

E. Middleton, B. Bullough, M. Zielezny, 1985, The Journal of allergy and clinical immunology.

Genetic LGALS1 Variants Are Associated with Heterogeneity in Galectin-1 Serum Levels in Patients with Early Arthritis

I. González-Álvaro, H. de la Fuente, E. Roy-Vallejo, 2022, International journal of molecular sciences.

Expression of miR-135b in Psoriatic Skin and Its Association with Disease Improvement

F. Sánchez‐Madrid, A. Vara, M. Llamas-Velasco, 2020, Cells.

Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis

I. González-Álvaro, S. Castañeda, E. Tomero, 2021, Journal of clinical medicine.

Is It Safe to Perform Joint Infiltrations or Aspirations in Patients Anticoagulated With Acenocoumarol

A. Boteanu, N. Montes, C. Quiñones, 2015 .

Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism

Cristina Municio, I. González-Álvaro, A. Puig-Kröger, 2018, Annals of the rheumatic diseases.

SAT0105 Preliminary analysis of genetic variants in the immune system related to the body mass index in early arthritis patients

J. Martín, A. Triguero, I. G. Álvaro, 2018, Saturday, 16 JUNE 2018.

IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study

T. Cavero, F. Sánchez‐Madrid, I. González-Álvaro, 2020, Journal of Allergy and Clinical Immunology.

Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis

I. González-Álvaro, S. Castañeda, H. de la Fuente, 2020, Scientific Reports.

Disease Activity Indices in Rheumatoid Arthritis: Comparative Performance to Detect Changes in Function, IL-6 Levels, and Radiographic Progression

L. Rodríguez-Rodríguez, L. Carmona, I. González-Álvaro, 2021, Frontiers in Medicine.

Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients

F. Sánchez‐Madrid, I. González-Álvaro, M. Orts, 2021, Scientific Reports.

Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study.

L. Rodríguez-Rodríguez, L. Carmona, I. González-Álvaro, 2018, Clinical and experimental rheumatology.

Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis

I. González-Álvaro, C. Muñoz‐Calleja, L. Cardeñoso, 2023, Frontiers in medicine.

Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patients with rheumatoid arthritis or psoriatic arthritis

I. González-Álvaro, A. Alfranca, E. Vicente-Rabaneda, 2024, NPJ vaccines.